The study of the ” Clinical Trials Market” provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.
The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Clinical trial is a part of clinical research that follows a regulated protocol. Clinical trials are primarily performed to get data on safety and efficacy of the new developed drug. Clinical trial data is mandatory for further approval of the drug and to bring it into the market.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/219570 .
The increasing disease burden is propelling the pharmaceutical and biotechnology industry to bring up new chemical entities into the market at a higher rate. Most companies are outsourcing the clinical trials of their newly developed drugs to various contract research organizations as this could save them the hassles of regulatory issues and patient recruitment burden from the research and development phase. Clinical trials allows the drug to be tested for safety by different ethnic population. Due to the higher medical needs and increasing disease prevalence, developing countries are becoming a hub for clinical trial execution. Since 2006, there has been an increased number of trials registered worldwide and it is estimated to increase further in the coming years, which would contribute to the market growth.
The United States and Canada have the highest market share in the clinical trials market, followed by Europe where Germany leads the market followed by Poland and Western Europe. Asia is one of the fastest growing markets. India, China, Singapore and South Korea are the major players involved in this market. This high growth is attributed to the fact that the cost involved in performing a trial is less and the huge domain it provides in the aspect of diseases and patients.
The report identifies the different trends and key opportunities in clinical trials market, and provides the market share of major segments and geographical regions. The major companies profiled in this report includes Quintiles, Paraxel, ICON Plc, PPD, and Charles River, among others. The report provides strategic insights on industry competition, and covers key facts, business overview, service portfolio, SWOT analysis and financial analysis of leading players in the market.
Some points from TOC:
1.1 Study Assumptions
1.2 Market Definition
- RESEARCH APPROACH AND METHODOLOGY
2.2 Analysis Methodology
2.3 Study Phases
2.3.1 Secondary Research
2.3.2 Discussion Guide
2.3.3 Market Engineering & Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
Purchase a copy of Global Clinical Trials Market visit @ http://www.orbisresearch.com/contact/purchase/219570 For more information contact firstname.lastname@example.org .
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
4.2 Clinical Trials Design
4.3 Clinical Trials Phases
4.4 Post Trials Marketing Structure
4.5 Safety Measures
4.6 Patient & Physician Recruitment
4.7 Ethical Values involved in the Clinical Trials
4.8 Regulatory Affairs
4.9 Clinical Trials Setup & Funding
For any enquires before buying, connect with us @ email@example.com
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research